Global Heart Transplantation Therapeutics Market 2024-2028

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4.1 Global heart transplantation therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global heart transplantation therapeutics market 2018 - 2022 ($ million)
4.2 Drug Class Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6.1 Market segments
Exhibit 30: Chart on Drug Class - Market share 2023-2028 (%)
Exhibit 31: Data Table on Drug Class - Market share 2023-2028 (%)
6.2 Comparison by Drug Class
Exhibit 32: Chart on Comparison by Drug Class
Exhibit 33: Data Table on Comparison by Drug Class
6.3 Immunosuppressants - Market size and forecast 2023-2028
Exhibit 34: Chart on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Immunosuppressants - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Immunosuppressants - Year-over-year growth 2023-2028 (%)
6.4 Anti-infectives - Market size and forecast 2023-2028
Exhibit 38: Chart on Anti-infectives - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Anti-infectives - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Anti-infectives - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Anti-infectives - Year-over-year growth 2023-2028 (%)
6.5 Analgesics - Market size and forecast 2023-2028
Exhibit 42: Chart on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Drug Class
Exhibit 50: Market opportunity by Drug Class ($ million)
Exhibit 51: Data Table on Market opportunity by Drug Class ($ million)

7.1 Market segments
Exhibit 52: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 68: Market opportunity by Distribution Channel ($ million)
Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Exhibit 107: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 119: AbbVie Inc. - Overview
Exhibit 120: AbbVie Inc. - Product / Service
Exhibit 121: AbbVie Inc. - Key news
Exhibit 122: AbbVie Inc. - Key offerings
12.4 Astellas Pharma Inc.
Exhibit 123: Astellas Pharma Inc. - Overview
Exhibit 124: Astellas Pharma Inc. - Product / Service
Exhibit 125: Astellas Pharma Inc. - Key news
Exhibit 126: Astellas Pharma Inc. - Key offerings
12.5 Biocon Ltd.
Exhibit 127: Biocon Ltd. - Overview
Exhibit 128: Biocon Ltd. - Business segments
Exhibit 129: Biocon Ltd. - Key offerings
Exhibit 130: Biocon Ltd. - Segment focus
12.6 Dr Reddys Laboratories Ltd.
Exhibit 131: Dr Reddys Laboratories Ltd. - Overview
Exhibit 132: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 133: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 134: Dr Reddys Laboratories Ltd. - Segment focus
12.7 F. Hoffmann La Roche Ltd.
Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
12.8 GlaxoSmithKline Plc
Exhibit 140: GlaxoSmithKline Plc - Overview
Exhibit 141: GlaxoSmithKline Plc - Business segments
Exhibit 142: GlaxoSmithKline Plc - Key news
Exhibit 143: GlaxoSmithKline Plc - Key offerings
Exhibit 144: GlaxoSmithKline Plc - Segment focus
12.9 Glenmark Pharmaceuticals Ltd.
Exhibit 145: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 146: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 147: Glenmark Pharmaceuticals Ltd. - Key offerings
12.10 Intas Pharmaceuticals Ltd.
Exhibit 148: Intas Pharmaceuticals Ltd. - Overview
Exhibit 149: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 150: Intas Pharmaceuticals Ltd. - Key offerings
12.11 LEO Pharma AS
Exhibit 151: LEO Pharma AS - Overview
Exhibit 152: LEO Pharma AS - Business segments
Exhibit 153: LEO Pharma AS - Key offerings
Exhibit 154: LEO Pharma AS - Segment focus
12.12 Lupin Ltd.
Exhibit 155: Lupin Ltd. - Overview
Exhibit 156: Lupin Ltd. - Product / Service
Exhibit 157: Lupin Ltd. - Key news
Exhibit 158: Lupin Ltd. - Key offerings
12.13 Novartis AG
Exhibit 159: Novartis AG - Overview
Exhibit 160: Novartis AG - Business segments
Exhibit 161: Novartis AG - Key offerings
Exhibit 162: Novartis AG - Segment focus
12.14 Panacea Biotec Ltd.
Exhibit 163: Panacea Biotec Ltd. - Overview
Exhibit 164: Panacea Biotec Ltd. - Product / Service
Exhibit 165: Panacea Biotec Ltd. - Key offerings
12.15 Pfizer Inc.
Exhibit 166: Pfizer Inc. - Overview
Exhibit 167: Pfizer Inc. - Product / Service
Exhibit 168: Pfizer Inc. - Key news
Exhibit 169: Pfizer Inc. - Key offerings
12.16 Sun Pharmaceutical Industries Ltd.
Exhibit 170: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 171: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 172: Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global heart transplantation therapeutics market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits 31: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Drug Class
Exhibits 33: Data Table on Comparison by Drug Class
Exhibits 34: Chart on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Immunosuppressants - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Immunosuppressants - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Anti-infectives - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Anti-infectives - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Anti-infectives - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Anti-infectives - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibits 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 50: Market opportunity by Drug Class ($ million)
Exhibits 51: Data Table on Market opportunity by Drug Class ($ million)
Exhibits 52: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 53: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 54: Chart on Comparison by Distribution Channel
Exhibits 55: Data Table on Comparison by Distribution Channel
Exhibits 56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 68: Market opportunity by Distribution Channel ($ million)
Exhibits 69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 108: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 109: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 111: Market opportunity By Geographical Landscape ($ million)
Exhibits 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 113: Impact of drivers and challenges in 2023 and 2028
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: AbbVie Inc. - Overview
Exhibits 120: AbbVie Inc. - Product / Service
Exhibits 121: AbbVie Inc. - Key news
Exhibits 122: AbbVie Inc. - Key offerings
Exhibits 123: Astellas Pharma Inc. - Overview
Exhibits 124: Astellas Pharma Inc. - Product / Service
Exhibits 125: Astellas Pharma Inc. - Key news
Exhibits 126: Astellas Pharma Inc. - Key offerings
Exhibits 127: Biocon Ltd. - Overview
Exhibits 128: Biocon Ltd. - Business segments
Exhibits 129: Biocon Ltd. - Key offerings
Exhibits 130: Biocon Ltd. - Segment focus
Exhibits 131: Dr Reddys Laboratories Ltd. - Overview
Exhibits 132: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 133: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 134: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 135: F. Hoffmann La Roche Ltd. - Overview
Exhibits 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 137: F. Hoffmann La Roche Ltd. - Key news
Exhibits 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 140: GlaxoSmithKline Plc - Overview
Exhibits 141: GlaxoSmithKline Plc - Business segments
Exhibits 142: GlaxoSmithKline Plc - Key news
Exhibits 143: GlaxoSmithKline Plc - Key offerings
Exhibits 144: GlaxoSmithKline Plc - Segment focus
Exhibits 145: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 146: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 147: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 148: Intas Pharmaceuticals Ltd. - Overview
Exhibits 149: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits 150: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits 151: LEO Pharma AS - Overview
Exhibits 152: LEO Pharma AS - Business segments
Exhibits 153: LEO Pharma AS - Key offerings
Exhibits 154: LEO Pharma AS - Segment focus
Exhibits 155: Lupin Ltd. - Overview
Exhibits 156: Lupin Ltd. - Product / Service
Exhibits 157: Lupin Ltd. - Key news
Exhibits 158: Lupin Ltd. - Key offerings
Exhibits 159: Novartis AG - Overview
Exhibits 160: Novartis AG - Business segments
Exhibits 161: Novartis AG - Key offerings
Exhibits 162: Novartis AG - Segment focus
Exhibits 163: Panacea Biotec Ltd. - Overview
Exhibits 164: Panacea Biotec Ltd. - Product / Service
Exhibits 165: Panacea Biotec Ltd. - Key offerings
Exhibits 166: Pfizer Inc. - Overview
Exhibits 167: Pfizer Inc. - Product / Service
Exhibits 168: Pfizer Inc. - Key news
Exhibits 169: Pfizer Inc. - Key offerings
Exhibits 170: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 171: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 172: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 173: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 174: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 175: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 176: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 177: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 178: Inclusions checklist
Exhibits 179: Exclusions checklist
Exhibits 180: Currency conversion rates for US$
Exhibits 181: Research methodology
Exhibits 182: Validation techniques employed for market sizing
Exhibits 183: Information sources
Exhibits 184: List of abbreviations